Analyst Ratings for ResMed (RMD) [Neutrals]
RMD Rating Summary
RMD Price Target Summary
- Highest: $40.00 (Canaccord Genuity)
- Lowest: $32.00 (Deutsche Bank)
- Average: $35.33
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$35.33 (-29.4%)
Avg. $ Target:
$35.33 (-29.4%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/26/2012 | Credit Suisse | Downgrade | Neutral (Outperform) |
N/A (N/A) |
41.34 | 50.07 | 21.12% | Details |
| 7/19/2012 | Feltl & Co | Downgrade | Hold (Buy) |
N/A (N/A) |
32.30 | 50.07 | 55.02% | Details |
| 4/30/2012 | BofA/Merrill Lynch | Downgrade | Neutral (N/A) |
N/A (N/A) |
34.11 | 50.07 | 46.79% | Details |
| 5/2/2011 | Morgan Stanley | Downgrade | Equalweight (N/A) |
N/A (N/A) |
33.92 | 50.07 | 47.61% | Details |
| 4/29/2011 | Mizuho Securities | Downgrade | Neutral (N/A) |
N/A (N/A) |
33.61 | 50.07 | 48.97% | Details |
